Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience

Author:

Arthur Douglas W,Koo Derrick,Zwicker Robert D,Tong Shidong,Bear Harry D,Kaplan Brian J,Kavanagh Brian D,Warwicke Laurel A,Holdford Diane,Amir Cyrus,Archer Kellie J,Schmidt-Ullrich Rupert K

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. A phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma. Radiation Therapy Oncology Group Publication No. 1055;Kuske,1995

2. Fifteen-year prognostic discriminants for invasive breast carcinoma—National Surgical Adjuvant Breast and Bowel Project Protocol B-06;Fischer;Cancer Suppl,2001

3. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer;Fischer;N Engl J Med,1995

4. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates;Schmidt-Ullrich;Int J Radiat Oncol Biol Phys,1993

5. Consensus statement: Treatment of early-stage breast cancer. NIH Consensus Development Conference, June 18–21, 1990. Vol. 8, No. 6,1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3